Cargando…
Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms
Presently, nanocarriers (NCs) have gained huge attention for their structural ability, good biocompatibility, and biodegradability. The development of effective NCs with stimuli-responsive properties has acquired a huge interest among scientists. When developing drug delivery NCs, the fundamental go...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944113/ https://www.ncbi.nlm.nih.gov/pubmed/35331246 http://dx.doi.org/10.1186/s12951-022-01364-2 |
_version_ | 1784673652928675840 |
---|---|
author | Kaushik, Neha Borkar, Shweta B. Nandanwar, Sondavid K. Panda, Pritam Kumar Choi, Eun Ha Kaushik, Nagendra Kumar |
author_facet | Kaushik, Neha Borkar, Shweta B. Nandanwar, Sondavid K. Panda, Pritam Kumar Choi, Eun Ha Kaushik, Nagendra Kumar |
author_sort | Kaushik, Neha |
collection | PubMed |
description | Presently, nanocarriers (NCs) have gained huge attention for their structural ability, good biocompatibility, and biodegradability. The development of effective NCs with stimuli-responsive properties has acquired a huge interest among scientists. When developing drug delivery NCs, the fundamental goal is to tackle the delivery-related problems associated with standard chemotherapy and to carry medicines to the intended sites of action while avoiding undesirable side effects. These nanocarriers were able of delivering drugs to tumors through regulating their pH, temperature, enzyme responsiveness. With the use of nanocarriers, chemotherapeutic drugs could be supplied to tumors more accurately that can equally encapsulate and deliver them. Material carriers for chemotherapeutic medicines are discussed in this review keeping in viewpoint of the structural properties and targeting methods that make these carriers more therapeutically effective, in addition to metabolic pathways triggered by drug-loaded NCs. Largely, the development of NCs countering to endogenous and exogenous stimuli in tumor regions and understanding of mechanisms would encourage the progress for tumor therapy and precision diagnosis in future. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-8944113 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-89441132022-03-25 Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms Kaushik, Neha Borkar, Shweta B. Nandanwar, Sondavid K. Panda, Pritam Kumar Choi, Eun Ha Kaushik, Nagendra Kumar J Nanobiotechnology Review Presently, nanocarriers (NCs) have gained huge attention for their structural ability, good biocompatibility, and biodegradability. The development of effective NCs with stimuli-responsive properties has acquired a huge interest among scientists. When developing drug delivery NCs, the fundamental goal is to tackle the delivery-related problems associated with standard chemotherapy and to carry medicines to the intended sites of action while avoiding undesirable side effects. These nanocarriers were able of delivering drugs to tumors through regulating their pH, temperature, enzyme responsiveness. With the use of nanocarriers, chemotherapeutic drugs could be supplied to tumors more accurately that can equally encapsulate and deliver them. Material carriers for chemotherapeutic medicines are discussed in this review keeping in viewpoint of the structural properties and targeting methods that make these carriers more therapeutically effective, in addition to metabolic pathways triggered by drug-loaded NCs. Largely, the development of NCs countering to endogenous and exogenous stimuli in tumor regions and understanding of mechanisms would encourage the progress for tumor therapy and precision diagnosis in future. GRAPHICAL ABSTRACT: [Image: see text] BioMed Central 2022-03-24 /pmc/articles/PMC8944113/ /pubmed/35331246 http://dx.doi.org/10.1186/s12951-022-01364-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Review Kaushik, Neha Borkar, Shweta B. Nandanwar, Sondavid K. Panda, Pritam Kumar Choi, Eun Ha Kaushik, Nagendra Kumar Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms |
title | Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms |
title_full | Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms |
title_fullStr | Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms |
title_full_unstemmed | Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms |
title_short | Nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms |
title_sort | nanocarrier cancer therapeutics with functional stimuli-responsive mechanisms |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8944113/ https://www.ncbi.nlm.nih.gov/pubmed/35331246 http://dx.doi.org/10.1186/s12951-022-01364-2 |
work_keys_str_mv | AT kaushikneha nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms AT borkarshwetab nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms AT nandanwarsondavidk nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms AT pandapritamkumar nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms AT choieunha nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms AT kaushiknagendrakumar nanocarriercancertherapeuticswithfunctionalstimuliresponsivemechanisms |